Connection
Cecilia Low Wang to Anticholesteremic Agents
This is a "connection" page, showing publications Cecilia Low Wang has written about Anticholesteremic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.174 |
|
|
|
-
Hess CN, Low Wang CC, Hiatt WR. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. Annu Rev Med. 2018 01 29; 69:133-145.
Score: 0.128
-
Wang CC, Reusch JE. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol. 2012 Nov 06; 110(9 Suppl):58B-68B.
Score: 0.045